In MMTV-PyMT spontaneous mammary carcinoma model, a unique TH1 CD4+ subset was identified in non-tumor peripheral tissues that rendered protective benefit when transferred into treatment-naïve tumor hosts challenged with 4T1 tumors (83). This evidence concerns the gene CD4 and breast carcinoma.